Results 101 to 110 of about 2,976 (190)

Correlation of tumor budding with a novel and other established prognostic parameters in patients with invasive breast carcinoma

open access: yesIndian Journal of Pathology and Microbiology
Context: Breast cancer is the most common malignancy among women. Established prognostic markers in breast carcinomas include tumor size, histologic grade, nodal status, lymphovascular invasion, perineural invasion, hormone receptor status, HER-2 status,
Neha D. Borde   +3 more
doaj   +1 more source

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients

open access: yesWorld Journal of Surgical Oncology, 2018
Background Prognosis of breast cancer and success of therapeutic interventions largely rely on the clinico-pathologic and biological characteristics of the tumor and vary due to the heterogeneous nature of breast cancers.
Atif Ali Hashmi   +10 more
doaj   +1 more source

Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial [PDF]

open access: yes, 2017
Background The cardiac safety of trastuzumab concurrent with pegylated liposomal doxorubicin (PLD) in an adjuvant breast cancer treatment regimen is unknown.
Bermejo, B.   +17 more
core  

Addressing Global Disparities in Breast Cancer by Transforming Surgical Pathology in Ethiopia: Early Implementation of Immunohistochemistry

open access: yesJCO Global Oncology
PURPOSESurgical pathology services are essential for breast cancer (BC) diagnosis and treatment. Building capacity in immunohistochemistry (IHC) is urgently needed in sub-Saharan Africa.
Lesley Taylor   +5 more
doaj   +1 more source

Metaplastic Carcinoma Breast in Polycythemic Octogenarian – Lessons Learnt: Case Report

open access: yesLietuvos Chirurgija
An 80-year-old lady presented with lump Left breast of 8 months duration. Clinically was aT4b lesion, sonomammogram showed BIRADS V lesion and core needle breast biopsy features were suggestive of metaplastic carcinoma breast of adenosquamous type, ER ...
Swarup Prabhu   +5 more
doaj   +3 more sources

Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span

open access: yesScientific Reports, 2017
Cancer vaccines are less effective at old than at young age because of immunosenescence. Besides, in preliminary observations we showed that the immunization with HER-2/neu DNA plasmid in transgenic young mice (standard immunization, SI) delays but not ...
Mauro Provinciali   +3 more
doaj   +1 more source

Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy [PDF]

open access: yes, 2017
Adjuvant therapy has improved the survival of women with early breast cancer (BC). Meta-analyses suggest that anthracycline-based regimens reduced the annual BC death rate by ∼40% in women below the age of 50 and 20% in older women. Novel agents designed
De Laurentiis, M.   +4 more
core  

Microchips and their significance in isolation of circulating tumor cells and monitoring of cancers [PDF]

open access: yes, 2016
In micro-fluid systems, fluids are injected into extremely narrow polymer channels in small amounts such as micro-, nano-, or pico-liter scales. These channels themselves are embedded on tiny chips.
Azad, M.   +4 more
core  

A case of pathological complete regression in combined modality treatment of resectable Her2/neu-positive gastric cancer

open access: yesСибирский онкологический журнал
Background. Overexpression of Her2neu occurs in 15–20% of patients with gastric cancer and correlates with an unfavorable prognosis. Case report.
A. V. Avgustinovich   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy